Chongqing zhifei Biological Products Co., Ltd. is a company mainly engaged in the marketing of biological products. The company distributes A+C meningococcal polysaccharide conjugate vaccine and A+C+Y+W 135 meningococcal polysaccharide vaccine. Haemophilus influenzae B conjugate vaccine, freeze-dried live attenuated hepatitis A vaccine, micro-card and other products (some of the above products are exclusively produced and sold in China, and there is no competition of similar products in China), and the marketing network covers 365,438+0 provinces/autonomous regions/municipalities and cities nationwide.
Chongqing zhifei Biological Products Co., Ltd. was established in 1995 with a registered capital of 360 million yuan, mainly engaged in biotechnology development and management. The company passed GSP certification in 2003 and has good software and hardware facilities for biological products management. Its three wholly-owned subsidiaries have their own scientific research and production bases, which are biotechnology high-tech group companies integrating scientific research, production and sales.
Corporate public welfare:
20 15-20 16, zhifei Bio participated in the activity of "helping 900 students" to help poor college students enter school as scheduled; 20 17 provide donations and public welfare funds to Taiyuan Charity Federation and China Women's Development Foundation. 20 18 Donated scholarships to the University Education Foundation of Chinese Academy of Sciences to support education and scientific research.
20 19 participated in poverty alleviation projects such as Guanyin Village in Gongcheng, Guilin, Tianyuan Township, Wuxi County, Chongqing, and "Chongqing cares for left-behind children in rural areas"; In 2020, donate money and materials to Linquan County, Anhui Province and Shizhu County, Chongqing to support the cause of precision poverty alleviation; Donated 1 10,000 yuan to Hubei in June 2020 to help prevent and control the epidemic.